News
10-23-2007, 09:30 AM
The U.S. Food and Drug Administration has approved Ixempra (ixabepilone), a new anti-cancer treatment, for use in patients with metastatic or locally advanced breast cancer who have not responded to certain other cancer drugs.
More... (http://www.news-medical.net/?id=31544)
More... (http://www.news-medical.net/?id=31544)